Patients with Crohn's disease on anti-tumor necrosis factor therapy are at significant risk of inadequate response to the 23-valent pneumococcal polysaccharide vaccine

Chang Kyun Lee, Hyun Soo Kim, Byong Duk Ye, Kang Moon Lee, You Sun Kim, Sang Youl Rhee, Hyo Jong Kim, Suk Kyun Yang, Won Moon, Ja Seol Koo, Suck Ho Lee, Geom Seog Seo, Soo Jung Park, Chang Hwan Choi, Sung Ae Jung, Sung Noh Hong, Jong Pil Im, Eun Soo Kim

Research output: Contribution to journal › Article › peer-review

47 Scopus citations

Fingerprint

Dive into the research topics of 'Patients with Crohn's disease on anti-tumor necrosis factor therapy are at significant risk of inadequate response to the 23-valent pneumococcal polysaccharide vaccine'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science